CMS Ready to Impose Plan Reform

Article

Dermatologists who administer chemotherapy and other drugs in their offices could see significant reductions in reimbursement levels as a result of an effort by the federal government to curtail Medicare's costs for drugs used to treat cancer.

Related Videos
Dr. Suneel Chilukuri
Health Care Impacts on Gender and Sexual Minority Patients
Caring for Gender and Sexual Minority Patients
Related Content

She Was Not 18. Could She Give Informed Consent?

September 28th 2023

The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice

February 18th 2021

5 Ways to Negotiate the Best Physician Employment Contract

August 28th 2023

5 Money Mistakes Dermatologists Make and How to Avoid Them

August 18th 2023

Disclosing Physician Health: What Is Required?

August 17th 2023

4 Key Tools to Protect Personal and Practice Assets

July 31st 2023

She Was Not 18. Could She Give Informed Consent?

September 28th 2023

The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice

February 18th 2021

5 Ways to Negotiate the Best Physician Employment Contract

August 28th 2023

5 Money Mistakes Dermatologists Make and How to Avoid Them

August 18th 2023

Disclosing Physician Health: What Is Required?

August 17th 2023

4 Key Tools to Protect Personal and Practice Assets

July 31st 2023

She Was Not 18. Could She Give Informed Consent?

September 28th 2023

The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice

February 18th 2021

5 Ways to Negotiate the Best Physician Employment Contract

August 28th 2023

5 Money Mistakes Dermatologists Make and How to Avoid Them

August 18th 2023

Disclosing Physician Health: What Is Required?

August 17th 2023

4 Key Tools to Protect Personal and Practice Assets

July 31st 2023
© 2023 MJH Life Sciences

All rights reserved.